Pathogenesis and Treatment of Myeloma-Related Bone Disease.

Gau, Yuh-Ching; Yeh, Tsung-Jang; Hsu, Chin-Mu; Hsiao, Samuel Yien; Hsiao, Hui-Hua

Gau, Yuh-Ching; Yeh, Tsung-Jang; Hsu, Chin-Mu; Hsiao, Samuel Yien; Hsiao, Hui-Hua.

Afiliação

Gau YC; Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan.
Yeh TJ; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Hsu CM; Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan.
Hsiao SY; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Hsiao HH; Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan.

Int J Mol Sci ; 23(6)2022 Mar 14.

Article em En | MEDLINE | ID: mdl-35328533

Assuntos

Doenças Ósseas; Mieloma Múltiplo; Doenças Ósseas/etiologia; Doenças Ósseas/patologia; Doenças Ósseas/terapia; Difosfonatos/uso terapêutico; Humanos; Mieloma Múltiplo/complicações; Mieloma Múltiplo/tratamento farmacológico; Osteoclastos/metabolismo; Ligante RANK/metabolismo; Microambiente Tumoral; Via de Sinalização Wnt

Palavras-chave

bisphosphonates; denosumab; myeloma; myeloma bone disease; novel agents; osteoclastogenesis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Ósseas / Mieloma Múltiplo Tipo de estudo: Etiology_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google